David Schaaf

David Schaaf

Company: Zogenix

Job title: Vice President, US Medical Affairs, Senior Medical Officer


Development of a New Medication for the Ultra-Rare Mitochondrial Disease Thymidine Kinase 2 Deficiency Disorder (TK2d) 2:30 pm

Reviewing TK2d disease whilst navigating natural history Evaluating the creation of NDA-supporting dataset Examining top-line results supporting NDA-submissionRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.